Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.

Grant CW, Duclos SK, Moran-Paul CM, Yahalom B, Tirabassi RS, Arreaza-Rubin G, Spain LM, Guberski DL.

Comp Med. 2012 Oct;62(5):381-90.

2.

Rhesus cytomegalovirus encodes seventeen microRNAs that are differentially expressed in vitro and in vivo.

Hancock MH, Tirabassi RS, Nelson JA.

Virology. 2012 Apr 10;425(2):133-42. doi: 10.1016/j.virol.2012.01.009. Epub 2012 Feb 2.

3.

A mucosal vaccination approach for herpes simplex virus type 2.

Tirabassi RS, Ace CI, Levchenko T, Torchilin VP, Selin LK, Nie S, Guberski DL, Yang K.

Vaccine. 2011 Jan 29;29(5):1090-8. doi: 10.1016/j.vaccine.2010.11.076. Epub 2010 Dec 4.

4.

Cytomegalovirus microRNA expression is tissue specific and is associated with persistence.

Meyer C, Grey F, Kreklywich CN, Andoh TF, Tirabassi RS, Orloff SL, Streblow DN.

J Virol. 2011 Jan;85(1):378-89. doi: 10.1128/JVI.01900-10. Epub 2010 Oct 27.

5.

Infection with viruses from several families triggers autoimmune diabetes in LEW*1WR1 rats: prevention of diabetes by maternal immunization.

Tirabassi RS, Guberski DL, Blankenhorn EP, Leif JH, Woda BA, Liu Z, Winans D, Greiner DL, Mordes JP.

Diabetes. 2010 Jan;59(1):110-8. doi: 10.2337/db09-0255. Epub 2009 Sep 30.

6.

A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection.

Yang K, Whalen BJ, Tirabassi RS, Selin LK, Levchenko TS, Torchilin VP, Kislauskis EH, Guberski DL.

J Immunol. 2008 May 1;180(9):6159-67.

7.

LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation.

Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL, Kislauskis EH, Tirabassi RS.

Diabetes. 2005 Sep;54(9):2727-33.

8.

The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus.

Tirabassi RS, Flanagan JF, Wu T, Kislauskis EH, Birckbichler PJ, Guberski DL.

ILAR J. 2004;45(3):292-302. Review.

PMID:
15229376
9.

Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies.

Kim M, Yang H, Kim SK, Reche PA, Tirabassi RS, Hussey RE, Chishti Y, Rheinwald JG, Morehead TJ, Zech T, Damon IK, Welsh RM, Reinherz EL.

J Biol Chem. 2004 Jun 11;279(24):25838-48. Epub 2004 Apr 7.

10.
11.
12.

Viral immune evasion strategies and the underlying cell biology.

Lorenzo ME, Ploegh HL, Tirabassi RS.

Semin Immunol. 2001 Feb;13(1):1-9. Review.

PMID:
11289794
13.

The role of virion membrane protein endocytosis in the herpesvirus life cycle.

Brideau AD, Enquist LW, Tirabassi RS.

J Clin Virol. 2000 Aug;17(2):69-82. Review.

PMID:
10942087
16.
17.

Molecular mechanisms of neurotropic herpesvirus invasion and spread in the CNS.

Tirabassi RS, Townley RA, Eldridge MG, Enquist LW.

Neurosci Biobehav Rev. 1998 Oct;22(6):709-20.

PMID:
9809306
18.

The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX.

Yuan J, Tirabassi RS, Bush AB, Cole MD.

Oncogene. 1998 Sep 3;17(9):1109-18.

19.

Supplemental Content

Loading ...
Support Center